Valuation: IRADIMED CORPORATION

Market Cap 1.2B 1.05B 980M 899M 1.69B 116B 1.72B 11.64B 4.55B 56.81B 4.5B 4.41B 196B P/E 2026 *
49.1x
P/E 2027 * 43.4x
Enterprise Value 1.2B 1.05B 980M 899M 1.69B 116B 1.72B 11.64B 4.55B 56.81B 4.5B 4.41B 196B EV / Sales 2026 *
13.2x
EV / Sales 2027 * 11.9x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day+0.67%
1 week-3.35%
Current month-1.12%
1 month+2.31%
3 months+6.41%
6 months-6.32%
Current year-2.87%
1 week 92.76
Extreme 92.765
98.46
1 month 90.83
Extreme 90.83
102.99
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Director/Board Member 73 01/01/2014
Director/Board Member 61 02/09/2025
Director/Board Member 70 01/01/2019
Date Insider Type Main position Quantity % Market Cap.
20/6/26 Fiscal year

Chief Financial Officer

13,911 0.1088%
4/6/26 Sell

Director

-3,000 0.0235%
1/6/26 Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+0.67%-3.35%+65.77%+104.66% 1.2B
-3.58%-1.75%-17.76%-19.58% 13.78B
-0.07%-4.54%+43.53%-8.66% 3.94B
-3.46%-8.35%-41.64%-61.88% 1.18B
-1.62%-6.53%-41.29%-48.24% 1.09B
-3.98%-8.02%-46.54% - 936M
-3.75%-16.04%+36.75%+72.97% 467M
-1.67%+1.56%+52.71% - 330M
-1.90%-1.62%-60.80%+228.43% 261M
-0.60%-10.08%+22.06%+37.42% 138M
Average -2.00%-2.46%+1.28%+38.14% 2.33B
Weighted average by Cap. -2.63%-4.23%-4.71%-9.29%

Financials

2026 *2027 *
Net sales 91.2M 80.1M 74.49M 68.36M 128M 8.78B 130M 885M 346M 4.32B 342M 335M 14.93B 101M 88.62M 82.42M 75.63M 142M 9.72B 144M 979M 382M 4.78B 379M 371M 16.52B
Net income 24.55M 21.56M 20.05M 18.4M 34.57M 2.36B 35.11M 238M 93.03M 1.16B 92.16M 90.17M 4.02B 27.8M 24.42M 22.71M 20.84M 39.15M 2.68B 39.75M 270M 105M 1.32B 104M 102M 4.55B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
25/07/26 USD 94.49 +0.67% 79,664
23/07/26 USD 93.86 -0.23% 82,772
22/07/26 USD 94.08 -0.94% 91,871
21/07/26 USD 94.97 -2.12% 126,070
20/07/26 USD 97.03 0.00% 75,920
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
93.86USD
Average target price
118.00USD
Spread / Average Target
+25.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock